Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential effects of nutrients and light on autophagy-mediated visual function and clearance of retinal aggregates.

Archives italiennes de biologie·2023
Same author

Combined pulses of light and sound in the retina with nutraceuticals may enhance the recovery of foveal holes.

Archives italiennes de biologie·2022
Same author

Noradrenergic substrates sensing light within brainstem reticular formation as targets for light-induced behavioral and cardiovascular plasticity.

Archives italiennes de biologie·2022
Same author

Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

Post-traumatic cerebral venous sinus thrombosis associated with epidural hematoma: A challenging clinical situation.

Neuro-Chirurgie·2022
Same author

The neurobiology of nutraceuticals combined with light exposure, a case report in the course of retinal degeneration.

Archives italiennes de biologie·2022

Related Experiment Video

Updated: May 20, 2026

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

Prion-like mechanisms in epileptogenesis.

F Orzi, B Casolla, R Rocchi

    Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
    |July 11, 2012
    PubMed
    Summary

    Epilepsy development involves a complex process called epileptogenesis after an initial brain injury. Emerging evidence suggests a prion-like mechanism, involving misfolded proteins, may drive this "maturation" phase.

    More Related Videos

    Pentylenetetrazole-Induced Kindling Mouse Model
    07:06

    Pentylenetetrazole-Induced Kindling Mouse Model

    Published on: June 12, 2018

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
    12:57

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

    Published on: January 8, 2015

    Related Experiment Videos

    Last Updated: May 20, 2026

    Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
    07:58

    Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

    Published on: September 15, 2011

    Pentylenetetrazole-Induced Kindling Mouse Model
    07:06

    Pentylenetetrazole-Induced Kindling Mouse Model

    Published on: June 12, 2018

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
    12:57

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

    Published on: January 8, 2015

    Area of Science:

    • Neuroscience
    • Pathology
    • Molecular Biology

    Background:

    • Epilepsy often arises after a focal brain insult, initiating a delayed pathological process known as epileptogenesis.
    • This process involves intricate nervous system responses, including both injury and repair mechanisms, leading to changes in neural excitability and network function.
    • A significant latent period can precede seizure onset, during which underlying molecular and cellular changes occur.

    Discussion:

    • The precise mechanisms driving epileptogenesis, particularly during the silent phase, remain uncertain.
    • This study explores the hypothesis that prion-like mechanisms contribute to the maturation of epilepsy.
    • Such mechanisms involve the aggregation of misfolded proteins and alterations in protein degradation pathways.

    Key Insights:

    • Prion-like mechanisms, characterized by self-aggregating misfolded proteins, are proposed to drive epileptogenesis.
    • Changes in the ubiquitin-proteasome system and autophagy-lysosome pathways are associated with this process.
    • This aligns with observations in other neurodegenerative diseases.

    Outlook:

    • Further research is needed to elucidate the role of prion-like mechanisms in epilepsy.
    • Understanding these pathways could reveal novel therapeutic targets for preventing or treating epilepsy.
    • Investigating protein misfolding and degradation offers a promising avenue for epilepsy research.